Jump to main content
Jump to site search

Issue 13, 2017
Previous Article Next Article

AuGd integrated nanoprobes for optical/MRI/CT triple-modal in vivo tumor imaging

Author affiliations

Abstract

Multi-modal imaging agents are desirable for tumor diagnosis because they can provide more information on the tumor than single-modal imaging agents. However, most reported multi-modal imaging agents are dual-modal agents rather than tri-modal agents; therefore, detailed information on the tumor may still be insufficient when such imaging agents are used. To ameliorate this issue, we synthesized a tri-modal imaging agent, composed of gold cluster and gadolinium oxide integrated nanoparticles (denoted as AuGds) using bovine serum albumin (BSA) as the template via a bio-mineralization method. The AuGds exhibit red fluorescence at ∼660 nm for optical imaging, strong X-ray absorption (around 700 HU) for CT imaging, and a high r1 value (∼12.39 mM−1 s−1) for MR imaging. After being chemically modified with folic acid (FA), the AuGds can specifically target folate receptors on KB tumor cells, and permit in vivo optical, MR, and CT imaging of xenografted tumors. By comparing these three imaging modalities, very clear structural and anatomical information on the in vivo tumor can be obtained. The AuGds show good biocompatibility, quick renal clearance, and do not induce normal tissue toxicity in vivo.

Graphical abstract: AuGd integrated nanoprobes for optical/MRI/CT triple-modal in vivo tumor imaging

Back to tab navigation

Supplementary files

Publication details

The article was received on 13 Feb 2017, accepted on 06 Mar 2017 and first published on 10 Mar 2017


Article type: Paper
DOI: 10.1039/C7NR01064H
Citation: Nanoscale, 2017,9, 4620-4628
  •   Request permissions

    AuGd integrated nanoprobes for optical/MRI/CT triple-modal in vivo tumor imaging

    C. Xu, Y. Wang, C. Zhang, Y. Jia, Y. Luo and X. Gao, Nanoscale, 2017, 9, 4620
    DOI: 10.1039/C7NR01064H

Search articles by author

Spotlight

Advertisements